Strive Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$709K Sell
1,957
-4,466
-70% -$1.53M 0.31% 47
2026
Q1
$2.26M Sell
6,423
-937
-13% -$334K 1.2% 19
2025
Q4
$2.41M Buy
+7,360
New +$2.33M 1.27% 18

Other funds holding AMGN

Strive Financial Group's AMGN Position: Q2 2026 in Review

Strive Financial Group reduced its Amgen (AMGN) stake by 70% in Q2 2026, selling an estimated $1.53M and leaving 1,957 shares worth $709K. The position accounts for 0.31% of the portfolio, ranked #47.

Strive Financial Group first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.41M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Strive Financial Group held 1,957 shares of Amgen worth $709K as of Q2 2026.
  • Strive Financial Group sold 4,466 Amgen shares in Q2 2026, an estimated $1.53M.
  • Amgen made up 0.31% of Strive Financial Group's portfolio in Q2 2026, its #47 holding.
  • Strive Financial Group first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Strive Financial Group's Amgen position peaked at $2.41M in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.